Voloridge Investment Management, LLC Organogenesis Holdings Inc. Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$4.74 - $8.15 $482,811 - $830,150	101,859 Added 38.98%	363,189 $1.77 Million
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $707,792 - $1.05 Million	109,396 Added 72.0%	261,330 $1.99 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $1.03 Million - $1.55 Million	114,697 Added 308.02%	151,934 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$13.71 - $17.18 $1.33 Million - $1.67 Million	-96,973 Reduced 72.25%	37,237 $530,000
Q2 2021 Aug 16, 2021	BUY	$14.92 - $23.23 $2 Million - $3.12 Million	134,210 New	134,210 $2.23 Million

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.